Uncan Pharmaceuticals Private Limited - Company Profile

It is a paper private limited company based in Cuttack Sadar, Orissa, India, established in 2024.
2024 Cuttack Sadar, Orissa, India Active
Last Updated:
Access Report
About Uncan Pharmaceuticals Private Limited

Uncan Pharmaceuticals Private Limited, a active private limited company, was established on 12 June 2024 in Cuttack Sadar, Orissa, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21002OD2024PTC046098. Registered under ROC Roc Cuttack. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹0.15 M.

Its leadership includes Rakesh Kumar Khadanga (Director), Prangyan Paramita Mishra (Director), Sasmita Mishra (Director). It is based at Plot No-196/1054, Millenium City,, Pahal, Cuttack Sadar, Orissa, 754001.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21002OD2024PTC046098

  • Registration Number

    046098

  • Incorporation Date

    12 June 2024

  • Authorized Capital

    ₹1.50 M

  • Paid-Up Capital

    ₹0.15 M

  • ROC Code

    Roc Cuttack

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.50 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 1 Year 8 Months
Company report

Uncan Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Uncan Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Uncan Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Rakesh Kumar Khadanga Director 12 Jun 2024 Current
Prangyan Paramita Mishra Director 12 Jun 2024 Current
Sasmita Mishra Director 12 Jun 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Uncan Pharmaceuticals.

Enhance accessibility to Uncan Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Uncan Pharmaceuticals revenue growth over time
Uncan Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Uncan Pharmaceuticals?

Unlock access to Uncan Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Uncan Pharmaceuticals?

Unlock and access historical data on people associated with Uncan Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Uncan Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uncan Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Uncan Pharmaceuticals
Recent Activity within the Organization
  • Director Appointment

    The activity Rakesh Kumar Khadanga was appointed as a Director was appointed as a Director on 12 Jun 2024 & has been associated with this company since 1 year 8 months . was completed.

  • Director Appointment

    The activity Prangyan Paramita Mishra was appointed as a Director was appointed as a Director on 12 Jun 2024 & has been associated with this company since 1 year 8 months . was completed.

  • Director Appointment

    The activity Sasmita Mishra was appointed as a Director was appointed as a Director on 12 Jun 2024 & has been associated with this company since 1 year 8 months . was completed.

  • Company Incorporation

    The activity Uncan Pharmaceuticals Private Limited was registered on 12 Jun 2024 with Roc Cuttack & aged 1 year 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Uncan Pharmaceuticals Private Limited?

The CIN of Uncan Pharmaceuticals Private Limited is U21002OD2024PTC046098.

Where is Uncan Pharmaceuticals Private Limited headquartered?

Uncan Pharmaceuticals Private Limited is headquartered at Plot No-196/1054, Millenium City,, Pahal, Cuttack Sadar, Orissa, 754001.

When was Uncan Pharmaceuticals Private Limited incorporated?

Uncan Pharmaceuticals Private Limited was incorporated on 12 June 2024.

Who are the current directors of Uncan Pharmaceuticals Private Limited?

The current directors of Uncan Pharmaceuticals Private Limited are

What is the primary industry of Uncan Pharmaceuticals Private Limited?

The primary industry of Uncan Pharmaceuticals Private Limited is Paper.

Is Uncan Pharmaceuticals Private Limited a listed company?

Uncan Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Uncan Pharmaceuticals Private Limited?

The authorized capital of Uncan Pharmaceuticals Private Limited is ₹1.50 M, and the paid-up capital is ₹0.15 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available